Snapshot from Sep 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech product launch

Philips launches eV14-2v transvaginal transducer

Analysis based on 6 articles · First reported Sep 03, 2026 · Last updated Sep 04, 2026

Sentiment
10
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The launch strengthens Philips' competitive position in the women's health ultrasound market, potentially driving sales growth. It may positively influence investor sentiment for Philips, though the impact is modest given the niche product segment.

Medical devices Healthcare Ultrasound imaging

Philips introduced the eV14-2v transvaginal transducer, expanding its obstetrics and gynecology ultrasound portfolio. The device is FDA 510(k) cleared and CE marked, designed to support a broad range of gynecology and early obstetrics exams. It offers a 41.7% increase in penetration, 10% improvement in 2D resolution, 15.8% wider field of view, and is 22% lighter compared to the 3D9-3v transducer. The transducer leverages PureWave crystal technology and is compatible with Philips Collaboration Live for remote consultations. It will be showcased at the 36th ISUOG World Congress. Philips highlights its commitment to advancing women's health and improving patient experience.

100 Philips introduced
stock
Philips introduced the eV14-2v transducer, expanding its ultrasound portfolio and reinforcing its focus on women's health. This product launch may support revenue growth in the ultrasound segment.
Importance 100.0 Sentiment 10.0
govactor
The FDA granted 510(k) clearance for the eV14-2v, a regulatory milestone that allows Philips to market the device in the United States.
Importance 30.0 Sentiment 0.0
per
Ajay Gannerkote, Ultrasound Business Leader at Philips, is quoted emphasizing the company's commitment to women's health and the benefits of the new transducer.
Importance 20.0 Sentiment 0.0
ngo
The ISUOG World Congress serves as the venue for showcasing the new transducer, providing a platform to reach key opinion leaders in obstetrics and gynecology ultrasound.
Importance 20.0 Sentiment 0.0
per
Dr. Michael, a clinician, provides a positive testimonial on the transducer's workflow and patient comfort benefits, supporting the product's value proposition.
Importance 15.0 Sentiment 0.0
priv
Perinatal Associates of New Mexico is mentioned as the practice of Dr. Ruma, serving as an early user reference for the product.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.